Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI0382 (Cotadutide) Effect on Energy Balance in T2DM and Obesity
NCT03596177Phase 2Completed
- Sponsor
- MedImmune
- Start
- Sep 2018
- Primary completion
- Dec 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cotadutide in type 2 diabetes mellitus (T2DM), obesity, sponsored by MedImmune. Started Sep 2018; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT03596177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03596177.